Tower Research Capital LLC (Trc) Bone Biologics Corp Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.19 - $32.7 $82 - $14,191
434 Added 5.51%
8,311 $2,000
Q3 2022

Nov 10, 2022
BUY
$0.16 - $35.1 $273 - $60,091
1,712 Added 27.77%
7,877 $8,000
Q2 2022

Aug 15, 2022
BUY
$0.14 - $0.41 $863 - $2,527
6,165 New
6,165 $9,000

About Bone Biologics Corp

BBLG Quotes by TradingView
  • Ticker BBLG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,128,400
  • Market Cap $18.8M
  • Description
  • Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...
More about BBLG
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email